Sex was not considered as a biological variable, given the low percentage of males in our study population, consistent with the greater percentage of females among the post-surgical population, limiting power for sex-specific analysis
While dual receptor co-agonism offers enhanced weight loss and metabolic benefits, it also appears to offer upside in mitigating GI AEs
This can help people who are sensitive to dose changes or who experience significant side effects
2006 Jun 30;126-127:250-257
It accesses doses lower than the usual starter doses on our other GLP-1 programs, as well as additional doses up to 25% of the standard maintenance dose
8-year trends in obesity, type 2 diabetes, and glucagon-like peptide-1 (GLP-1) use in patients with obstructive sleep apnea